Calidi Biotherapeutics, Inc. Share Price
CLDICalidi Biotherapeutics, Inc. Stock Performance
Open $1.60 | Prev. Close $1.61 | Circuit Range N/A |
Day Range $1.60 - $1.60 | Year Range $1.53 - $45.36 | Volume 609 |
Average Traded $1.60 |
Calidi Biotherapeutics, Inc. Share Price Chart
About Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States. Its product pipeline comprises CLD-101, which is in Phase 1b/2 clinical trial for the treatment of high-grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck squamous cell carcinoma, and soft tissue sarcoma, which is in pre-clinical studies; CLD-301 for multiple indications, which is in preclinical studies; and CLD-400 for certain lung cancer and metastatic solid tumors. The company also offers oncolytic virus platforms, such as NeuroNova, SuperNova, and RTNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.
Calidi Biotherapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
15-Sep-25 | $1.60 | $1.60 | -0.62% |
12-Sep-25 | $1.61 | $1.61 | -0.92% |
11-Sep-25 | $1.63 | $1.63 | -1.52% |
10-Sep-25 | $1.65 | $1.65 | +0.92% |
09-Sep-25 | $1.60 | $1.64 | -0.61% |
08-Sep-25 | $1.65 | $1.65 | +4.11% |
05-Sep-25 | $1.58 | $1.58 | +0.64% |
FAQs on Calidi Biotherapeutics, Inc. Share Price
Can I buy Calidi Biotherapeutics, Inc. shares in India?
What is the share price of Calidi Biotherapeutics, Inc.?
What is the 5 year returns of Calidi Biotherapeutics, Inc.?
What are the high & low stock price of Calidi Biotherapeutics, Inc. today?
What is the 52-week high and low of Calidi Biotherapeutics, Inc. stock?